UnknownNot Applicable

Less Frequency Hemodialysis and COVID-19

Argentina50 participantsStarted 2020-03-20

Plain-language summary

Facing the unusual situation imposed by the coronavirus disease, the aim of this study is to evaluate the risk and effects of less frequent hemodialysis on prevalent patients

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * More than 30 days of Chronic ambulatory in-center hemodialysis Exclusion Criteria: * More than three sessions a week * amputated lower limbs

What they're measuring

Mortality

Timeframe: From date of beginning of the study until the date of death assessed up to 52 weeks

Trial details

NCT IDNCT04374058

SponsorDialisis Madariaga

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-03

View on ClinicalTrials.gov More End Stage Renal Disease trials